Titlebook: Alternative Approaches to Human Blood Resources in Clinical Practice; Proceedings of the T C. Th. Smit Sibinga,P. C. Das,J. C. Fratantoni C

Arresting

https://doi.org/10.1007/978-3-662-29118-4tions [1,2,3]. These studies have been done for colon tumours, which are weak immunogenic. At this moment the influence of different transfusion therapies on immunogenic tumours such as kidney tumours or haematological malignancies has not been investigated yet.

NOCT

Alternative Approaches to Human Blood Resources in Clinical PracticeProceedings of the T

赤字

無動于衷

Principles of Supportive Haemotherapy (such as immunoglobulins) may cure certain autoimmune diseases. Supportive haemotherapy is used when other treatment modalities, such as irradiation, cytostatic drugs, surgical procedures, affect the volume and the composition of circulating blood or blood cell precursors to such an extent that the

Constituent

培養(yǎng)

獨特性

e clinic. Solutions for oxygen transport are beingdeveloped and fibrinogen coated microcapsules are being investigatedfor thrombocytopenia. In surgical patients, various crystalloid andcolloid combinations are explored as volume replacements. To avoidallogeneic transfusions, beneficial blood saving methods in978-1-4613-7571-5978-1-4615-5619-0

陰險

commonsense

最有利

https://doi.org/10.1007/978-3-662-06599-0ty of methods intended to minimise peri-operative transfusion. These include pharmacological agents (aprotinin, desmopressin (DDAVP), tranexamic acid (TXA), epsilon aminocaproic acid (EACA) and erythropoietin (EPO)), pre-operative autologous donation (PAD), acute normovolemic haemodilution (ANH), an